Commercialization Experts

Angel Investor and Board MemberBoston Harbor Angels

Henry Kay is on the Boards of Directors of several Life science companies in the US and Canada and is an active angel investor.

CommercializationMedical DevicesInvestingVenture CapitalStrategy

Managing DirectorLumira Ventures

Gerry Brunk is a venture capital investor with expertise in biotechnology, medical devices, start-ups and corporate strategy.

Business StrategyMedical DevicesPharmaceutical IndustryDrug DevelopmentCommercialization

CEO and Co-founderSanaRx Biotherapeutics

Rick Pierce is a senior level executive and advisor, with expertise in attracting capital, forging transformative strategic alliances .

Strategic PlanningMedical DevicesTechnology TransferLifesciencesPharmaceutical Industry

Manager, Technology & Venture Development (Head, Molecular Diagnostics)MaRS Innovation

Commercializing life science technologies in the areas of molecular diagnostics, medical devices and therapeutics

Molecular Cell BiologyMolecular DiagnosticsLife SciencesCommercializationProject and Program Management

CEOGenomadix

Steve Edgett has more than 20 years of experience in business development, strategic planning, and international markets.

Communications TechnologiesInternational MarketsStrategic PlanningNew MarketsBusiness Strategy

PartnerFlow Ventures

Accomplished Venture and Angel Capital Investment, Entrepreneurship and Funding Industry Professional

Angel Investing in CanadaVenture Capital & Private Equity InvestingGovernment FundingTax CreditsCommercialization of Innovation

Managing DirectorARTIFEX ADVISORS

Managing Director at ARTIFEX ADVISORS

Disruptive InnovationBig DataPrivacyPrivacy and Security for Online CompaniesPrivacy and Security of Health Information

Director, Intellectual PropertyMaRS Innovation

Experienced and strategy-minded director with extensive experience managing commercially driven programs

Intellectual Property StrategyAccess to Essential MedicinesBiotechnology Patent ProtectionEarly Stage Commercialization

Vice President & Head, Business Development & Alliance ManagementVertex Pharmaceuticals

Phil Tinmouth manages highly valuable and strategic collaborations in the biotechnology industry.

CommercializationPharmaceutical IndustryBusiness DevelopmentStrategyBiotechnology

DirectorCentre for Business and Social Entrepreneurship

Responsible for leading the University of Guelph's technology transfer and industrial liaison office.

EntrepreneurshipStart-UpsBusiness PlanningStrategic PlanningMarketing Strategy

commercialization Experts